A natural product inhibits the initiation of a-synuclein aggregation & suppresses its toxicity
Resumen: The self-Assembly of a-synuclein is closely associated with Parkinson''s disease and related syndromes. We show that squalamine, a natural product with known anticancer and antiviral activity, dramatically affects a-synuclein aggregation in vitro and in vivo. We elucidate the mechanism of action of squalamine by investigating its interaction with lipid vesicles, which are known to stimulate nucleation, and find that this compound displaces a-synuclein from the surfaces of such vesicles, thereby blocking the first steps in its aggregation process. We also show that squalamine almost completely suppresses the toxicity of a-synuclein oligomers in human neuroblastoma cells by inhibiting their interactions with lipid membranes. We further examine the effects of squalamine in a Caenorhabditis elegans strain overexpressing a-synuclein, observing a dramatic reduction of a-synuclein aggregation and an almost complete elimination of muscle paralysis. These findings suggest that squalamine could be a means of therapeutic intervention in Parkinson''s disease and related conditions.
Idioma: Inglés
DOI: 10.1073/pnas.1610586114
Año: 2017
Publicado en: Proceedings of the National Academy of Sciences 114, 6 (2017), E1009-E1017
ISSN: 0027-8424

Factor impacto JCR: 9.504 (2017)
Categ. JCR: MULTIDISCIPLINARY SCIENCES rank: 5 / 64 = 0.078 (2017) - Q1 - T1
Factor impacto SCIMAGO: 6.092 - Multidisciplinary (Q1)

Financiación: info:eu-repo/grantAgreement/ES/MINECO/RYC-2012-12068
Tipo y forma: Article (Published version)
Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)
Exportado de SIDERAL (2019-07-09-11:40:44)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
articulos



 Notice créée le 2017-05-11, modifiée le 2019-07-09


Versión publicada:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)